跳至主要内容
临床试验/NCT00561535
NCT00561535已完成2 期

Effect of a Probiotic, Lactobacillus FARCIMINIS, in Diarrhea Predominant IBS

Assistance Publique - Hôpitaux de Paris2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2007年10月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
60
试验地点
2
主要终点
Overall subject's assessment

研究概览

简要总结

Probiotics may improve symptoms in IBS patients. The aim of this study is to test the efficacy of Lactobacillus FARCIMINIS in diarrhea predominant IBS patients according to Rome III criteria.

详细描述

The aim of this study is to test the efficacy of Lactobacillus FARCIMINIS in diarrhea predominant IBS patients according to Rome III criteria.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diarrhea predominant IBS
  • Less than 5-year duration
  • Pain intensity between 2 and 7 on VAS

排除标准

  • Celiac disease
  • Antibiotic treatment within the 1-month period preceding inclusion
  • Digestive organic disease
  • Any severe non digestive organic disease

结局指标

主要结局

Overall subject's assessment

时间窗: 4 weeks

次要结局

  • Decrease in abdominal pain, stool form and consistency, modifications in intestinal permeability, modification in fecal serine protease activity, modifications in interleukin seric concentrations(4 weeks)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Effect of a Probiotic, Lactobacillus FARCIMINIS, in... | 临床试验